D
Sell
4/22/2016Downgrade
CardioGenics Holdings Inc (CGNH) was downgraded to D from D+ on 4/22/2016 due to a decline in the total return index, volatility index and solvency index.
D
Sell
3/28/2016Upgraded
CardioGenics Holdings Inc (CGNH) was upgraded to D+ from D on 3/28/2016 due to an increase in the total return index and volatility index.
D
Sell
3/11/2016Downgrade
CardioGenics Holdings Inc (CGNH) was downgraded to D from C on 3/11/2016 due to a substantial decline in the volatility index and total return index.
C
Hold
3/4/2016Upgraded
CardioGenics Holdings Inc (CGNH) was upgraded to C from C- on 3/4/2016 due to an increase in the growth index and total return index. EBIT increased 212.01% from -$99.9 to -$311.7.
C
Hold
1/12/2016Downgrade
CardioGenics Holdings Inc (CGNH) was downgraded to C- from C on 1/12/2016 due to a decline in the total return index.
C
Hold
12/28/2015Upgraded
CardioGenics Holdings Inc (CGNH) was upgraded to C from C- on 12/28/2015 due to an increase in the total return index, efficiency index and growth index. Operating cash flow increased 61.73% from -$100.6 to -$162.7, and total capital increased 34.61% from -$1.11M to -$1.5M.
C
Hold
9/23/2014Upgraded
CardioGenics Holdings Inc (CGNH) was upgraded to C- from D on 9/23/2014 due to a significant increase in the efficiency index, growth index and valuation index. Net income increased 66.45% from -$339.8 to -$565.6, and total capital increased 55.58% from -$777.4 to -$1.21M.
D
Sell
4/21/2014Downgrade
CardioGenics Holdings Inc (CGNH) was downgraded to D from D+ on 4/21/2014 due to a decline in the total return index.
D
Sell
4/4/2014Upgraded
CardioGenics Holdings Inc (CGNH) was upgraded to D+ from D on 4/4/2014 due to an increase in the growth index.
D
Sell
3/20/2014Downgrade
CardioGenics Holdings Inc (CGNH) was downgraded to D from D+ on 3/20/2014 due to a decline in the growth index and total return index. EBIT declined 84.39% from -$1.68M to -$262.2, and earnings per share declined from -$0.0391 to -$0.01.
